SCHEMBL8912878

SCHEMBL8912878

Cc1ccc2nc(-c3ccccc3-c3nnn(C(c4ccccc4)(c4ccccc4)c4ccccc4)n3)cc(Cl)c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.40
KDM4E B2RXH2 7/20 0.36
ALDH1A1 P00352 6/20 0.36
NPSR1 Q6W5P4 3/20 0.36
HSD17B10 Q99714 2/20 0.36
HPGD P15428 2/20 0.36
USP2 O75604 1/20 0.36
TSHR P16473 1/20 0.36
MAPT P10636 5/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
MEN1 O00255 1/20 0.35
RECQL P46063 1/20 0.35
KMT2A Q03164 1/20 0.35
AGTR1 P30556 1/20 0.35
ACSS2 Q9NR19 2/20 0.32
NFKB1 P19838 1/20 0.32
CASP3 P42574 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8913418 0.84 ALDH1A1 (0.37) LMNAKDM4EALDH1A1NPSR1MAPT
SCHEMBL9136146 0.78 AGTR1 (0.34) LMNAKDM4EALDH1A1MAPTNPC1
SCHEMBL9309617 0.77 MAPT (0.34) KDM4EALDH1A1HSD17B10HPGDMAPT
SCHEMBL8913223 0.77 AGTR1 (0.49) AGTR1
SCHEMBL9137228 0.76 KDM4E (0.33) KDM4EALDH1A1MAPTNPC1RAB9A
SCHEMBL4638846 0.75 ABCG2 (0.46) LMNAKDM4EALDH1A1HPGDTSHR
SCHEMBL9311085 0.74 FGFR1 (0.38) LMNAKDM4EALDH1A1HSD17B10HPGD
SCHEMBL9311096 0.74 AGTR1 (0.33) AGTR1
SCHEMBL9135278 0.74 AGTR1 (0.34) LMNAALDH1A1AGTR1
SCHEMBL9136773 0.74 ALDH1A1 (0.37) KDM4EALDH1A1NPSR1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5665881-A CARDIOVASCULAR DISORDERS, HYPOTENSIVE, ANGIOTENSIN II ANTAGONIST THE GREEN CROSS CORPORATION (JP) 1997-09-09 US disclosed
EP-0569013-B1 Quinoline compounds as angiotensin II antagonists GREEN CROSS CORP (JP) 1996-08-28 EP disclosed
EP-0693478-A1 Quinoline compounds THE GREEN CROSS CORPORATION (JP) 1996-01-24 EP disclosed
US-5478832-A Angiotensin II antagonists; cardiovascular disorders THE GREEN CROSS CORPORATION (JP) 1995-12-26 US disclosed
EP-0569013-A1 Quinoline compounds as angiotensin II antagonists THE GREEN CROSS CORPORATION (JP) 1993-11-10 EP disclosed